Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12613000621718
Ethics application status
Not yet submitted
Date submitted
29/05/2013
Date registered
30/05/2013
Date last updated
30/05/2013
Type of registration
Prospectively registered
Titles & IDs
Public title
Comparison of three methods of sputum clearance in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD).
Query!
Scientific title
In patients with an acute exacerbation of COPD, do positive expiratory pressure (PEP) devices, compared to standard physiotherapy exercises, reduce patient reported symptoms of breathlessness, cough and sputum.
Query!
Secondary ID [1]
282591
0
None
Query!
Universal Trial Number (UTN)
1111-1142-1941
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
289282
0
Query!
Condition category
Condition code
Respiratory
289606
289606
0
0
Query!
Chronic obstructive pulmonary disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment arm 1. A variable resistance positive expiratory pressure (PEP) device (TheraPEP 'Registered Trademark'), it has six resistance setting with pressures ranging from 10cmH2O to 20cmH2O.
The participant will be instructed to sit upright with elbows resting on a table holding the theraPEP 'Registered Trademark' device in front of them. The participant will be instructed to seal their lips around the mouth piece and exhale with a little force for three seconds only so the blue disc rises and reaches between the lower and upper black line. They will repeat this for 10 breaths, followed by two huffs (Forced expiratory technique (FET) – a demonstration maybe helpful) and a cough.
The full set will be repeated two more times to complete each session. There will be a two minute rest between each set. The first treatment session will be supervised and participants will be instructed to complete two further unsupervised sessions, one in the afternoon and another later that night. Participants will complete a diary after each treatment session.
Participants will be shown how to and instructed to increase the resistance if they are reaching the top black line too easily as per the usual method of use.
Treatment arm 2 - Bubble-PEP is a threshold resistor PEP system constructed using a plastic bottle, 10cm water and flexible plastic tubing. Bubble-PEP to be set up with 10cm of water (line marked on the bottle), a length of suction tubing placed down the handle of a two litre new plastic bottle.
The bubble-PEP device will be set up on a table in front of the participant with the participant sitting upright. Participants will be instructed to seal their lips around the tubing and exhale with a little force for three seconds only to create bubbles. Participants will repeat this for 10 breaths, followed by two huffs (FET – a demonstration maybe helpful) and a cough.
The full set is to be repeated two more times to complete the treatment session. There will be a two minute rest between each set. Participants will be supervised for their first session and a handout given. Participants will be instructed to complete 2 further unsupervised sessions, one in the afternoon and one later that night. Participants will complete a diary after each treatment session.
The water in the bottle will be changed after each treatment session and refilled to the marked line to ensure 10cm of water as per the Counties Manukau District Health Board (CMDHB) bubble–PEP device procedure
Query!
Intervention code [1]
287259
0
Treatment: Devices
Query!
Comparator / control treatment
Treatment arm 3 -Standard physiotherapy breathing exercises (Active cycle of breathing technique (ACBT))
With participants sitting upright, they will be are instructed to take three slow deep breaths in through their nose, followed by three relaxed breaths. Three more slow deep breaths, followed by three relaxed breaths with two huffs (forced expiratory technique (FET) – a demonstration maybe helpful) and a cough.
This full set is repeated two more times to complete one treatment session. There will be a two minute rest between each set. The first treatment session will be supervised and a handout will be provided. Participants will be instructed to complete two further treatment sessions independently, one in the afternoon and another later that night. Participants will complete a diary after each treatment session.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
289698
0
Breathlessness, cough and sputum scale (BCSS)
Query!
Assessment method [1]
289698
0
Query!
Timepoint [1]
289698
0
Baseline, 30min after each treatment session on day 1(3 treatment sessions), Reassessment on day 2
Query!
Secondary outcome [1]
303045
0
Length of hospital stay
Query!
Assessment method [1]
303045
0
Query!
Timepoint [1]
303045
0
On discharge from this hospital admission
Query!
Secondary outcome [2]
303046
0
Ease of expectoration on visual analogue scale
Query!
Assessment method [2]
303046
0
Query!
Timepoint [2]
303046
0
At baseline, 30min after each treatment session on day 1 (3 sessions) and at reassessment on day 2.
Query!
Secondary outcome [3]
303047
0
Lung function specifically forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) as measured by bedside spirometry
Query!
Assessment method [3]
303047
0
Query!
Timepoint [3]
303047
0
At baseline assessment, 40min after first treatment session, at reassessment on day 2.
Query!
Secondary outcome [4]
303048
0
Health-related quality of life (HRQoL) - COPD Assessment Test (CAT).
Query!
Assessment method [4]
303048
0
Query!
Timepoint [4]
303048
0
At baseline, 40minutes after first supervised treatment session and at reassessment on day 2.
Query!
Eligibility
Key inclusion criteria
Diagnosis of mild, moderate or severe COPD (as defined by spirometry) based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
18 years or over.
Admitted to Middlemore Hospital medical wards.
Exacerbation with reported sputum based on GOLD definition from COPDx Guidelines (An exacerbation is an event in the natural course of the disease characterised by a change in the patient’s baseline dyspnoea, cough, and/or sputum that is beyond normal day-to-day variations, is acute in onset, and may warrant a change in regular medication in a patient with underlying COPD)
English speaking and reading
Consent to research
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Non English speaking or reading
Unable to complete questionnaires or actively participate in treatment for any other reason (medical, physical, psychological)
Any previous PEP use at home
Receiving Bilevel positive airway pressure (BiPAP) treatment (as already receiving a form of positive pressure)
Any contraindications to PEP - large bullous disease, undrained pneumothorax
Any contraindications to airway clearance techniques, namely frank haemoptysis
Any patients previously recruited into this trial on any other admission
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Patients admitted with an AECOPD will be identified as per standard practice from the ward handover sheets every morning and from daily ward handover meetings. Randomisation will occur (via envelopes) just after the initial assessment, after participants have been deemed eligible, consented and assessed
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer generated randomisation codes will be allocated to the participants individual research code.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
24/06/2013
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
75
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
5120
0
New Zealand
Query!
State/province [1]
5120
0
Auckland
Query!
Funding & Sponsors
Funding source category [1]
287373
0
Hospital
Query!
Name [1]
287373
0
Counties Manukau District Health Board, Research Office, Tupu Research Fund
Query!
Address [1]
287373
0
CMDHB Research Office
Room 253, Level 2
Clinical Support Building
Private Bag 93 311
Auckland 1640
Query!
Country [1]
287373
0
New Zealand
Query!
Primary sponsor type
Individual
Query!
Name
Brigitte Eastwood
Query!
Address
Middlemore Hospital
Counties Manukau Health
Private Bag 93 311
Auckland 1640
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
286119
0
Individual
Query!
Name [1]
286119
0
Katie Coulter
Query!
Address [1]
286119
0
Counties Manukau Health
Private Bag 93 311
Auckland 1640
Query!
Country [1]
286119
0
New Zealand
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
289348
0
Health and Disability Ethics Committee
Query!
Ethics committee address [1]
289348
0
Ministry of Health
No 1 The Terrace
PO Box 5013
Wellington 6145
Query!
Ethics committee country [1]
289348
0
New Zealand
Query!
Date submitted for ethics approval [1]
289348
0
28/05/2013
Query!
Approval date [1]
289348
0
Query!
Ethics approval number [1]
289348
0
Query!
Summary
Brief summary
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder defined by airflow limitation that is not fully reversible. Individuals diagnosed with COPD present with chronic and progressive breathlessness, cough, and often sputum production. Positive expiratory pressure (PEP) is a form of airway clearance that works by splinting the airways open on expiration and allowing greater movement of air, it has been found to be an effective form of immediate airway clearance. Commercial PEP devices are expensive; however an alternative form of PEP that is inexpensive and is being used by New Zealand and Australian physiotherapists in the treatment of COPD is bubble-PEP. Despite bubble-PEP being used regularly there is limited evidence that assesses the effectiveness of it for its use in secretion clearance in the COPD population.
The aim of the study is to assess the effect of bubble-PEP compared with theraPEP 'Registered Trademark' (a type of commercially available PEP) and standard physiotherapy in patients with an acute exacerbation of COPD (AECOPD). The study aims to determine if 1, bubble-PEP has a greater effect on participant reported symptoms of breathlessness, cough and sputum compared with standard physiotherapy; 2, bubble-PEP is comparable to theraPEP 'Registered Trademark'.
The study hypothesis is that bubble-PEP will have a greater effect on participant reported symptoms than standard physiotherapy and that bubble-PEP will be as effective as the commercial product theraPEP 'Registered Trademark'.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
40418
0
Miss Brigitte Eastwood
Query!
Address
40418
0
Counties Manukau Health
Private Bag 93311
Auckland 1640
Query!
Country
40418
0
New Zealand
Query!
Phone
40418
0
+6492760207
Query!
Fax
40418
0
Query!
Email
40418
0
[email protected]
Query!
Contact person for public queries
Name
40419
0
Miss Brigitte Eastwood
Query!
Address
40419
0
Counties Manukau Health
Private Bag 93311
Auckland 1640
Query!
Country
40419
0
New Zealand
Query!
Phone
40419
0
+6492760207
Query!
Fax
40419
0
Query!
Email
40419
0
[email protected]
Query!
Contact person for scientific queries
Name
40420
0
Miss Brigitte Eastwood
Query!
Address
40420
0
Counties Manukau Health
Private Bag 93311
Auckland 1640
Query!
Country
40420
0
New Zealand
Query!
Phone
40420
0
+6492760207
Query!
Fax
40420
0
Query!
Email
40420
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF